Clinical trial
Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost…
NCT00440011 · Allergan, Industry · Completed
Key facts
| NCT number | NCT00440011 |
|---|---|
| Title | Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005% |
| Lead sponsor | Allergan, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Glaucoma, Ocular Hypertension |
| Intervention type | Drug |
| Interventions | bimatoprost 0.03% eye drops, travoprost 0.004% eye drops |
| Enrollment | 266 |
| Start date | Aug 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Feb 26, 2007 |
| Last update posted | Apr 25, 2019 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: